Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies

Overview of attention for article published in Journal of Pancreatic Cancer, October 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies https://t.co/oAc3xvkeJ6 #pancreaticcancer #oncology https://t.co/HmL…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.